MedTrace Logo

Docetaxel in Treating Patients With Advanced Cancer of the Cervix

NCT00003445 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2013-06-26

No results posted yet for this study

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

PURPOSE: Phase II trial to study the effectiveness of docetaxel in treating patients with advanced cancer of the cervix.

Conditions

Interventions

DRUG

docetaxel

Sponsors & Collaborators

  • Grupo Oncologico Cooperativo del Sur

    lead OTHER

Principal Investigators

  • Carlos Teodoro Vallejo, MD · Grupo Oncologico Cooperativo del Sur

Study Design

Purpose
TREATMENT

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-12-31
Completion
2004-04-30

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003445 on ClinicalTrials.gov